Immunosuppressant Drug Labels Updated To Reflect Infection Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA requires the labels for a handful of immunosuppressants used in kidney transplantation to reflect risk of infection, including activation of latent viral infections.